$14.37
0[0.00%]
At close: Apr 25
$14.37
0[0.00%]
PreMarket: 4:00PM EDT
Macrogenics
(NASDAQ:MGNX)Macrogenics Stock (NASDAQ:MGNX), Analyst Ratings, Price Targets, Predictions
Macrogenics Inc has a consensus price target of $16.07, established from looking at the 50 latest analyst ratings. The last 3 analyst ratings were released from TD Cowen, JMP Securities, and Citigroup on April 9, 2024, April 4, 2024, and March 11, 2024. With an average price target of $8.33 between TD Cowen, JMP Securities, and Citigroup, there's an implied -42.01% downside for Macrogenics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
JMP Securities
Citigroup
HC Wainwright & Co.
BMO Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Macrogenics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/09/2024 | MGNX | Buy Now | Macrogenics | $14.37 | — | TD Cowen | Boris Peaker | — | Upgrade | Hold → Buy | Get Alert |
| 04/04/2024 | MGNX | Buy Now | Macrogenics | $14.37 | — | JMP Securities | Silvan Tuerkcan | — | Reiterates | → Market Outperform | Get Alert |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 73.97% | Citigroup | Yigal Nochomovitz | $13 → $25 | Maintains | Buy | Get Alert |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 53.1% | JMP Securities | Silvan Tuerkcan | $16 → $22 | Maintains | Outperform | Get Alert |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 11.34% | HC Wainwright & Co. | Robert Burns | $14 → $16 | Maintains | Neutral | Get Alert |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 67.01% | BMO Capital | Etzer Darout | $18 → $24 | Maintains | Outperform | Get Alert |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 101.81% | Stifel | Stephen Willey | $17 → $29 | Maintains | Buy | Get Alert |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 73.97% | Barclays | Peter Lawson | $23 → $25 | Maintains | Overweight | Get Alert |
| 03/04/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 67.01% | BTIG | Kaveri Pohlman | $12 → $24 | Maintains | Buy | Get Alert |
| 02/29/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 60.06% | Barclays | Peter Lawson | $12 → $23 | Maintains | Overweight | Get Alert |
| 02/14/2024 | MGNX | Buy Now | Macrogenics | $14.37 | -2.57% | HC Wainwright & Co. | Robert Burns | $12 → $14 | Downgrade | Buy → Neutral | Get Alert |
| 01/24/2024 | MGNX | Buy Now | Macrogenics | $14.37 | 11.34% | JMP Securities | Silvan Tuerkcan | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 12/20/2023 | MGNX | Buy Now | Macrogenics | $14.37 | -9.53% | Citigroup | Yigal Nochomovitz | $7 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 11/27/2023 | MGNX | Buy Now | Macrogenics | $14.37 | 18.3% | Stifel | Jonathan Block | → $17 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | MGNX | Buy Now | Macrogenics | $14.37 | -16.49% | HC Wainwright & Co. | Robert Burns | $14 → $12 | Maintains | Buy | Get Alert |
| 11/07/2023 | MGNX | Buy Now | Macrogenics | $14.37 | -16.49% | Guggenheim | Charles Zhu | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2023 | MGNX | Buy Now | Macrogenics | $14.37 | -2.57% | HC Wainwright & Co. | Robert Burns | → $14 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | MGNX | Buy Now | Macrogenics | $14.37 | -30.41% | JMP Securities | Silvan Tuerkcan | $8 → $10 | Maintains | Market Outperform | Get Alert |
| 04/03/2023 | MGNX | Buy Now | Macrogenics | $14.37 | -2.57% | HC Wainwright & Co. | Robert Burns | → $14 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Macrogenics (MGNX)?
The latest price target for Macrogenics (NASDAQ: MGNX) was reported by TD Cowen on April 9, 2024. The analyst firm set a price target for $0.00 expecting MGNX to fall to within 12 months (a possible -100.00% downside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Macrogenics (MGNX)?
The latest analyst rating for Macrogenics (NASDAQ: MGNX) was provided by TD Cowen, and Macrogenics upgraded their buy rating.
When was the last upgrade for Macrogenics (MGNX)?
The last upgrade for Macrogenics Inc happened on April 9, 2024 when TD Cowen raised their price target to N/A. TD Cowen previously had a hold for Macrogenics Inc.
When was the last downgrade for Macrogenics (MGNX)?
The last downgrade for Macrogenics Inc happened on February 14, 2024 when HC Wainwright & Co. changed their price target from $12 to $14 for Macrogenics Inc.
When is the next analyst rating going to be posted or updated for Macrogenics (MGNX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Macrogenics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Macrogenics was filed on April 9, 2024 so you should expect the next rating to be made available sometime around April 9, 2025.
Is the Analyst Rating Macrogenics (MGNX) correct?
While ratings are subjective and will change, the latest Macrogenics (MGNX) rating was a upgraded with a price target of $0.00 to $0.00. The current price Macrogenics (MGNX) is trading at is $14.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.